Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06177717 · ClinicalTrials.gov registry record
Deep Functional Phenotyping of the ALA Lung Health Cohort
A clinical trial of Lung Diseases, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 12
- Study locations
NCT06177717 is a study of Lung Diseases that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 1,000 participants, above the 707-participant average among 31 other Lung Diseases trials with a reported enrollment target (41% higher). The trial reports 12 study locations across 11 states.
The verdict
NCT06177717, a study of Lung Diseases, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 12
- Study locations
Study Summary
The goal of this observational study is to learn about lung structure and function in a group of 1000 healthy people aged 25 to 35. The main questions it aims to answer are whether people's bodies, environment, and general lung health are associated with: * the structure of the participants lungs' airways, * the structure of blood vessels in the participants lungs and heart, and * the participants lungs' ability to exchange gases. Participants will take four different lung function tests to measure lung function, including: * air movement in the lungs (oscillometry) * lung size (slow vital capacity (SVC) and functional residual capacity (FRC) * gas transfer in the lungs (diffusing capacity for carbon monoxide (DLCO).
Conditions Studied
Study Locations (12)
North Carolina
- Duke University - Durham
- Wake Forest School of Medicine - Winston-Salem
Alabama
- University of Alabama - Birmingham
California
- University of California, Los Angeles - Los Angeles
Colorado
- National Jewish Health - Denver
Florida
- Nemours Children's Jacksonville - Jacksonville
Illinois
- Northwestern University - Chicago
Kansas
- University of Kansas - Kansas City
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2024-02-12 |
| Est. Completion | 2026-07-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06177717
The ClinicalTrials.gov registry entry for NCT06177717 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 707-participant average among 31 other Lung Diseases trials with a reported enrollment target (41% higher). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT06177717 reports 12 study locations spanning 11 distinct geographic areas - top geographies include North Carolina, Alabama, California.
Frequently Asked Questions
What is clinical trial NCT06177717 about?
NCT06177717 is a clinical study titled "Deep Functional Phenotyping of the ALA Lung Health Cohort". The goal of this observational study is to learn about lung structure and function in a group of 1000 healthy people aged 25 to 35. The main questions it aims to answer are whether people's bodies, environment, and general lung health are associated with: * the structure of the participants lungs' ...
What is the current status of trial NCT06177717?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2024-02-12. Estimated completion is 2026-07-30.
What conditions does trial NCT06177717 study?
This clinical trial studies the following conditions: Lung Diseases.
Who is sponsoring clinical trial NCT06177717?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06177717 being conducted?
This trial has 12 study locations across Alabama, California, Colorado, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
RECRUITING · Phase 2
-
Real World Registry for Use of the Ion Endoluminal System
RECRUITING
-
American Lung Association (ALA) Lung Health Cohort
RECRUITING
-
Data Collection Using Eko Digital Devices in a Clinical Setting
RECRUITING
-
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
RECRUITING · Phase 2
-
Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.